EULAR recommendations for the management of systemic lupus erythematosus: 2023 updateAntonis Fanouriakis, Dimitrios T. Boumpas, Chetan Mukhtyar et al.|Annals of the Rheumatic Diseases|2023Cited by 913
Treat-to-target in systemic lupus erythematosus: recommendations from an international task forceRonald van Vollenhoven, Matthias Schneider, Marta Mosca et al.|Annals of the Rheumatic Diseases|2014Cited by 726
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)Ronald van Vollenhoven, Murray B. Urowitz, Alexandre E. Voskuyl et al.|Annals of the Rheumatic Diseases|2016Cited by 355
2021 DORIS definition of remission in SLE: final recommendations from an international task forceRonald van Vollenhoven, Y K Onno Teng, George Βertsias et al.|Lupus Science & Medicine|2021Cited by 340
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)Michelle Petri, Marta Mosca, Ian N Bruce et al.|The Lancet|2023Cited by 164